These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11758308)

  • 1. Report from the Swedish Council on Technology Assessment in Health Care (SBU). Chemotherapy for cancer.
    Int J Technol Assess Health Care; 2001; 17(4):632-40. PubMed ID: 11758308
    [No Abstract]   [Full Text] [Related]  

  • 2. The Swedish Council on Technology Assessment in Health Care (SBU) report on Cancer Chemotherapy--Project objectives, the working process, key definitions and general aspects on cancer trial methodology and interpretation.
    Nygren P; Glimelius B;
    Acta Oncol; 2001; 40(2-3):155-65. PubMed ID: 11441928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytostatic therapy in cancer--a SBU report].
    Glimelius B; Nygren P; Lamnevik G
    Lakartidningen; 2001 Apr; 98(16):1905-10. PubMed ID: 11370407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Report from the Swedish Council on Technology Assessment in Health Care (SBU). Treatment of alcohol and drug abuse: an evidence-based review.
    Int J Technol Assess Health Care; 2002; 18(1):145-54. PubMed ID: 11987438
    [No Abstract]   [Full Text] [Related]  

  • 5. The Swedish Council on Technology Assessment in Health Care (SBU) systematic overview of chemotherapy effects in some major tumour types--summary and conclusions.
    Glimelius B; Bergh J; Brandt L; Brorsson B; Gunnars B; Hafström L; Haglund U; Högberg T; Janunger KG; Jönsson PE; Karlsson G; Kimby E; Lamnevik G; Nilsson S; Permert J; Ragnhammar P; Sörenson S; Nygren P
    Acta Oncol; 2001; 40(2-3):135-54. PubMed ID: 11441927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sickness absence: causes, consequences, and physicians' sickness certification practice. A systematic literature review by the Swedish Council on Technology Assessment in Health Care (SBU).
    Swedish Council on Technology Assessment in Health Care
    Scand J Public Health Suppl; 2004; 63():3-263. PubMed ID: 15513647
    [No Abstract]   [Full Text] [Related]  

  • 7. Moderately elevated blood pressure. A report from SBU, the Swedish Council on Technology Assessment in Health Care.
    J Intern Med Suppl; 1995; 737():1-225. PubMed ID: 9043531
    [No Abstract]   [Full Text] [Related]  

  • 8. Reports from the Swedish Council on Technology Assessment in Health Care (SBU).
    Int J Technol Assess Health Care; 1999; 15(2):424-36. PubMed ID: 10507199
    [No Abstract]   [Full Text] [Related]  

  • 9. Reports from the Swedish Council on Technology Assessment in Health Care (SBU). Urinary incontinence.
    Int J Technol Assess Health Care; 2000; 16(2):722-6. PubMed ID: 10932438
    [No Abstract]   [Full Text] [Related]  

  • 10. [The Dutch Health Council report on palliative chemotherapy: possible confusion on ideas].
    Verweij J; de Mulder PH; Pinedo HM
    Ned Tijdschr Geneeskd; 2004 Apr; 148(14):651-4. PubMed ID: 15106314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revise the review process of the Cochrane collaboration.
    Rosén M; Lindqvist R; Stenbeck M
    Scand J Public Health; 2002; 30(3):238-9. PubMed ID: 12227981
    [No Abstract]   [Full Text] [Related]  

  • 12. Moderately elevated blood pressure. A report from SBU, The Swedish Council on Technology Assessment in Health Care.
    J Intern Med; 1995; 238 Suppl 737():1-225. PubMed ID: 9422043
    [No Abstract]   [Full Text] [Related]  

  • 13. Swedish Council on Technology Assessment in Health Care (SBU). Chapter 1. Aim, background, key concepts, regulations, and current statistics.
    Alexanderson K; Norlund A
    Scand J Public Health Suppl; 2004; 63():12-30. PubMed ID: 15513650
    [No Abstract]   [Full Text] [Related]  

  • 14. [Should chemotherapy or endocrine therapy be used as first choice in patients with advanced breast cancer? A status article based on the Cochrane analysis "Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer"].
    Ejlertsen B; Mouridsen H
    Ugeskr Laeger; 2004 Jun; 166(25):2434-6. PubMed ID: 15283108
    [No Abstract]   [Full Text] [Related]  

  • 15. [The health technology assessment].
    Corrao S; Arnone S; Sicurello F
    Recenti Prog Med; 2004 Nov; 95(11):529-34. PubMed ID: 15598091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Costs of cancer chemotherapy].
    Kjaer M
    Ugeskr Laeger; 1994 Jan; 156(4):449-50. PubMed ID: 8140659
    [No Abstract]   [Full Text] [Related]  

  • 18. Measuring the validity of early health technology assessment: bibliometrics as a tool to indicate its scientific basis.
    Lundberg J; Brommels M; Skår J; Tomson G
    Int J Technol Assess Health Care; 2008; 24(1):70-5. PubMed ID: 18218171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Swedish Council on Technology Assessment in Health Care (SBU). Chapter 3. Causes of sickness absence: research approaches and explanatory models.
    Allebeck P; Mastekaasa A
    Scand J Public Health Suppl; 2004; 63():36-43. PubMed ID: 15513652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Swedish Council on Technology Assessment in Health Care (SBU). Chapter 4. Methodological aspects in sickness-absence research.
    Hensing G
    Scand J Public Health Suppl; 2004; 63():44-8. PubMed ID: 15513653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.